Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China · Delayed Price · Currency is CNY 170.61
+0.11 (0.06%)
May 8, 2026, 3:08 PM CST
SHE:300760 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 7,837 | 8,136 | 11,668 | 11,582 | 9,607 | 8,002 |
Depreciation & Amortization | 1,699 | 1,699 | 1,469 | 1,010 | 885.06 | 700.41 |
Other Amortization | 47.65 | 47.65 | 34.42 | 29.16 | 26.31 | 16.65 |
Loss (Gain) From Sale of Assets | -10.72 | -10.72 | -4.24 | -2.46 | -6.16 | -4.07 |
Asset Writedown & Restructuring Costs | 16.47 | 16.47 | 1.75 | 274.92 | 0.74 | 0.62 |
Loss (Gain) From Sale of Investments | -115.44 | -115.44 | -178.72 | -69.56 | 5.06 | -0.81 |
Provision & Write-off of Bad Debts | 195.27 | 195.27 | 298.93 | 244.18 | 36.78 | -5.94 |
Other Operating Activities | 956.6 | 771.05 | 388.97 | 33.63 | -145.31 | -103.06 |
Change in Accounts Receivable | -345.55 | -345.55 | -347.15 | -680.91 | -1,047 | -153.44 |
Change in Inventory | -677.85 | -677.85 | -782.05 | -201.43 | -523.01 | -133.63 |
Change in Accounts Payable | 583.91 | 583.91 | 402.21 | -769.19 | 3,094 | 615.09 |
Change in Other Net Operating Assets | -177.47 | -177.47 | -78.85 | 253.87 | 382.89 | 5.4 |
Operating Cash Flow | 10,032 | 10,145 | 12,432 | 11,062 | 12,141 | 8,999 |
Operating Cash Flow Growth | -9.31% | -18.40% | 12.38% | -8.89% | 34.92% | 1.45% |
Capital Expenditures | -2,141 | -2,038 | -1,959 | -2,689 | -1,916 | -1,402 |
Sale of Property, Plant & Equipment | 46.23 | 38.42 | 30.74 | 21.66 | 73.33 | 21.73 |
Cash Acquisitions | - | - | -5,773 | -870.82 | - | -3,520 |
Investment in Securities | 1,247 | 1,348 | 311.61 | 2,689 | -1,558 | - |
Other Investing Activities | 142.6 | 142.32 | 7.18 | 156.15 | 180.02 | 88.32 |
Investing Cash Flow | -705.33 | -509.4 | -7,383 | -692.93 | -3,220 | -4,812 |
Long-Term Debt Issued | - | 19.71 | 15.14 | - | - | - |
Total Debt Issued | 19.76 | 19.71 | 15.14 | - | - | - |
Long-Term Debt Repaid | - | -162.08 | -162.94 | -142.46 | -103.35 | -537.94 |
Total Debt Repaid | -165.44 | -162.08 | -162.94 | -142.46 | -103.35 | -537.94 |
Net Debt Issued (Repaid) | -145.67 | -142.37 | -147.79 | -142.46 | -103.35 | -537.94 |
Issuance of Common Stock | - | - | - | - | 152.43 | - |
Repurchase of Common Stock | -148.93 | -148.93 | -5.4 | -6.08 | -999.94 | -999.99 |
Common Dividends Paid | -5,615 | -5,615 | -8,743 | -10,670 | -4,233 | -3,039 |
Other Financing Activities | -1,184 | -817.77 | 13.98 | 42.47 | -10.54 | -27.71 |
Financing Cash Flow | -7,093 | -6,724 | -8,882 | -10,776 | -5,194 | -4,605 |
Foreign Exchange Rate Adjustments | -451.12 | -194.71 | 72.19 | 101.37 | 113.82 | -171.45 |
Net Cash Flow | 1,782 | 2,717 | -3,761 | -305.22 | 3,841 | -589.78 |
Free Cash Flow | 7,890 | 8,107 | 10,473 | 8,373 | 10,226 | 7,596 |
Free Cash Flow Growth | -12.40% | -22.59% | 25.07% | -18.11% | 34.62% | -1.19% |
Free Cash Flow Margin | 23.63% | 24.36% | 28.52% | 23.97% | 33.67% | 30.06% |
Free Cash Flow Per Share | 6.51 | 6.69 | 8.65 | 6.91 | 8.45 | 6.25 |
Cash Income Tax Paid | 2,399 | 2,387 | 3,293 | 3,100 | 2,712 | 2,069 |
Levered Free Cash Flow | 5,997 | 6,213 | 6,577 | 3,871 | 7,485 | 4,887 |
Unlevered Free Cash Flow | 6,012 | 6,228 | 6,590 | 3,879 | 7,492 | 4,893 |
Change in Working Capital | -594.54 | -594.54 | -1,246 | -2,040 | 1,731 | 393.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.